This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Diabetic Retinopathy Market

Market Insights on Diabetic Retinopathy covering sales outlook, demand forecast & up-to-date key trends

Diabetic Retinopathy Market by Type, Management & Region - Forecast 2022 - 2032

Diabetic Retinopathy Market Outlook (2022-2032)

[324 Pages Report] The diabetic retinopathy market is likely to grow with an estimated CAGR of 5.8% from 2022 to 2032. The diabetic retinopathy market share was worth US$ 8.4 Bn in 2022.

Due to the increasingly high demand for diabetic retinopathy for damaged eye-retina patients on which, the diabetic retinopathy manufacturers are anticipated to generate high revenue of US$ 14.8 Bn by 2032.

"Demand for diabetic retinopathy is increasing with the complication related eye which is likely to treat with various eye injections and laser treatment for the disease are anticipated to increase the diabetic retinopathy market share in the forecast period from 2022 to 2032".

Attributes

Details

Diabetic Retinopathy Market CAGR (2022-2032)

5.8%

Diabetic Retinopathy Market Size (2022)

US$ 8.4 Bn

Diabetic Retinopathy Market Share (2032)

US$ 14.8 Bn

The patients keep in the medical conditions and are likely to examine by the doctors and experts, which leads to an increase in the diabetic retinopathy market size in the forecast period.

Cure the diabetic retinopathy disease that occurs due to unclear vision, blurriness, loss of central vision, and eye floaters, which are likely to increase the sales of diabetic retinopathy treatment.

Due to the symptoms such as blockage in the retina veins on which supply of blood unable to reach the retina which causes this disease which anticipated to increase in the adoption of diabetic retinopathy.

The doctors monitor the diseases to check the conditions of the patient's eye & likely to adopt the laser treatment or medical treatment, whichever is necessary. Due to this factor, the diabetic retinopathy market growth is anticipated to boost the economy all around the globe.

Hence, the adoption of diabetic retinopathy is generating high revenue and is likely to overcome the rental disease by using an advanced technique by the doctors and medical field.

This disease is caused by several factors such as high blood pressure, excess use of tobacco during pregnancy, diabetes patients, anemia, and others, which are rising the demand for diabetic retinopathy treatment.

To overcome the disease, treatment, as well as self-care, is essential as per the doctor's advice which helps to fight the diabetic retinopathy. The manufacturing companies are likely to rising the production such as medicine, devices, and other necessary kits, which is increasing the diabetic retinopathy market share.

Several medical experts are testing, monitoring, and working to cure the critical condition of diabetic retinopathy in better ways. This leads to rising in the diabetic retinopathy statistic in the coming year.

It is likely to progress in the medical field and grow the diabetic retinopathy market's key trends and opportunities during the forecast period from 2022 to 2032.

Customize this Report

Let us know your requirement to get
100% FREE customization

What is the COVID-19 Impact on Diabetic Retinopathy Market?

COVID-19 waves directly affect the diabetic retinopathy market share due to the unavailability and limiting of resources during the lockdowns period, which is likely to decline the sales of diabetic retinopathy.

COVID-19 crisis put negative waves on the healthcare sectors all around the world, which supposed to hamper the diabetic retinopathy market growth.

The several eye treatment and operations were postponed, and the patient suffered a lot of health issues. The emergency ward was open in case of any urgent cases, and the patients avoiding go to the hospital during the pandemics, which was likely to slow down the diabetic retinopathy market size.

Hospitals, Clinics, Eye-care centers, and other hospitals were temporary close the advanced services related to diabetic retinopathy treatment as per the diabetic retinopathy market survey.

What are the Key Diabetic Retinopathy Market Dynamics?

The manufacturing industries and other research institutes are likely to increase the production of diabetic retinopathy devices and medicine to increase the growth of the diabetic retinopathy market share in the coming years.

These are the key industries making a focal point on the adoption of diabetic retinopathy to generate huge revenue by making a better quality of diabetic retinopathy devices in the market.

The end-user companies are Hospitals, Clinics, Multi-specialist hospitals, healthcare centers, and others are anticipated to boost the diabetic retinopathy market analysis as per the diabetic retinopathy market future trends.

The diabetic retinopathy market is going to boost the lion’s share in the coming forecast period from 2022 to 2032 as end-users are anticipated to increase in demand for diabetic retinopathy. This factor is rising the diabetic retinopathy market trends in the forthcoming year.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Diabetics Retinopathy Market

Diabetics Retinopathy Market:

Attributes

Diabetics Retinopathy Market

CAGR (2022-2032)

5.8%

Market Value (2022)

US$ 8.4 Billion

Growth Factor

Increasing number of diabetic & number of diabetic retinopathy patient leads to increase the growth of diabetic retinopathy market growth.

Opportunity

Diabetic retinopathy products launch by the leading companies & using strategies including partnerships, agreements, collaboration etc.

Key Trends

Rising better quality of treatment with the adoption of advance technologies for better cure.

Cardiovascular Device Market:

Attributes

Cardiovascular Device Market

CAGR (2022-2032)

7%

Market Value (2022)

US$ 57.56 Billion

Growth Factor

Rising the number of heart diseases, irregular heartbeats & rhythm disorders.

Opportunity

Public and private hospital are anticipated to increase the opportunities to deal with cardiovascular manufacturing companies.

Key Trends

Advance cardiovascular diagnostic and therapeutically devices.

Chronic Kidney Disease Market:

Attributes

Chronic Kidney Disease Market

CAGR (2022-2032)

6.5%

Market Value (2022)

US$ 790.1 Million

Growth Factor

Increasing kidney diseases & kidney failure rising the growth of chronic kidney diseases market.

Opportunity

Medical equipment, using drug to cure and therapies.

Key Trends

Advanced stage treatment includes kidney transplant and dialysis.

The above table is the comparative view of the adjacent diabetic retinopathy market with the cardiovascular device market and chronic kidney disease market during the forecast period from 2022 to 2032.

The sales of diabetic retinopathy are lifting due to various diabetic retinopathy devices being adopted by the patients. The manufacturer plays a vital role in the diabetic retinopathy market analysis in the forecast period.

The disease mainly occurs between the age group of 31 to 45 years as per diabetic retinopathy market report, including SBP, HbA1c, and others.

The poor condition of diabetes for a long period generates the disease. Therefore in the US, 12% of people cause blindness between the age group of 20 to 65 years, which is likely to increase the adoption of diabetic retinopathy worldwide.

It shows exactly no symptoms of blurry vision or loss of vision during the mild or starting of the diabetic retinopathy disease. This factor is likely to rise the diabetic retinopathy market size in the forecast period.

Adopting better quality diabetic eye disease treatment in the future by the specialist is likely to rises the diabetic retinopathy key market trends and opportunities.

Which Segment Dominates the Diabetic Retinopathy Market, by Type?

By type segment, the diabetic retinopathy market is likely to categorize into proliferative and non-proliferative. The proliferative segment is likely to dominate the diabetic retinopathy market size in the forecast period from 2022 to 2032.

The non-proliferative type segment is estimated with a CAGR of 5.7% during the forecast period from 2022 to 2032. It is increasing the number of medical conditions all around the globe & due to this, the manufacturers are likely to boost the diabetic retinopathy market share in the forthcoming year.

According to a new market research report on diabetic retinopathy, this segment is likely to be prominent & rises in the diabetic retinopathy market trends in the coming years.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Segment is Likely to Lead the Diabetic Retinopathy Market, by Management?

Based on management, laser surgery is anticipated to dominate the diabetic retinopathy market growth as compared to other segments, including anti-VEGF, Intraocular steroid injection, and vitrectomy. The adoption of diabetic retinopathy is likely to grow the height of the market through the laser surgery segment in the forecast period from 2022 to 2032.

The laser surgery segment is estimated with a CAGR of 5.9% during the forecast period from 2022 to 2032. Laser surgery is accessible in the market & patients are more comfortable with the acceptance of this procedure. Therefore, laser surgery surges the diabetic retinopathy market trends and forecasts in the coming year.

It is a friendly procedure as compared to other segments. Therefore, it is likely anticipated to boost the economy and generate revenue in the diabetic retinopathy market adoption in the forthcoming year.

What is the Regional Analysis for the Diabetic Retinopathy Market?

Region Historic CAGR (2015-2021)
US Market Size 6.1%
UK Market Size 5.4%
China Market Size 5.7%
Japan Market Size 4.8%
South Korea Market Size 4.7%
Region CAGR (2022-2032)
US Market Size 5.5%
UK Market Size 4.5%
China Market Size 5.1%
Japan Market Size 4.2%
South Korea Market Size 3.7%

The diabetic retinopathy market size is likely to increase all around the region, which is segmented by North America, Asia Pacific, Europe, Latin America, and other regions. The North American region is dominating all the remaining regions in the growth of diabetic retinopathy market trends in the forecast period from 2022 to 2032.

The US country is estimated to dominate the diabetic retinopathy market all around the globe due to the widespread production and distribution of diabetic retinopathy devices and products worldwide. The US market is estimated with a higher CAGR of 5.5% in the forecast period from 2022 to 2032.

The government of the US initiative plans and policies for the growth of the market, and due to well-established infrastructure, the demand for diabetic retinopathy is supposed to increase all around the regions.

China stood in the second position in the adoption of diabetic retinopathy in the Asia-Pacific region, with a CAGR of 5.1% in the forecast period from 2022 to 2032.

The rising awareness, increasing population, and rise in disposable income are likely to boost the diabetic retinopathy market size in the forecast period in the Asia-Pacific region.

The UK is estimating a higher growth in the diabetic retinopathy market and is likely to surge the high revenue with a CAGR of 4.5% in the forecast period.

Other countries such as Japan and South Korea are supposed to grow the diabetic retinopathy market in the coming year. All these regions are looking forward to growing the market higher & contributing to the healthcare sector.

How is the Competition in the Diabetic Retinopathy Market?

The end use industries and manufacturing companies play a key role in surging the diabetic retinopathy market size. The sales of diabetic retinopathy are likely to rise in these industries by capturing the tactics including mergers, collaboration, and partnerships.

Some of the key companies are present to highlight the lion’s share in the diabetic retinopathy market. These are Bayer Healthcare, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc, Oxurion, and others.

These industries prefer better quality treatment devices and medical uses in the diabetic retinopathy market trends and opportunities in the coming year.

Recent Developments in the Diabetic Retinopathy Market

  • The management team of medical control the blood glucose, blood lipids as well as blood pressure in the diabetic retinopathy market in the recent development.
  • Management of the Clinical team tried to reduce the clinically important retinopathy by around 30 to 75%, laser photocoagulation by around 35% and the first appearance of diabetic retinopathy by around 25% in the recent 4 years.
  • There is expecting to decline in blindness to adopt the diabetic retinopathy treatment.
  • Adoption of laser surgery is likely to overshadow the development of diabetic retinopathy.

Key Segments

By Type:

  • Proliferative
  • Non-proliferative

By Management:

  • Anti VEGF
  • Intraocular Steroid Injection
  • Laser Surgery
  • Vitrectomy

By Region:

  • North America
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • Latin America

Frequently Asked Questions

The diabetic retinopathy market is estimated to register a CAGR of 5.8%, during the forecast period (2022 - 2032).

During the projected period, the U.S. is expected to lead the diabetic retinopathy market by 2032.

By type, the non-proliferative type segment is dominating over the forecast period.

The diabetic retinopathy market is expected to be valued at US$ 14.8 Billion by 2032.

The diabetic retinopathy market size accounted for around US$ 7.9 Billion in 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Diabetic Retinopathy Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points 

    4.1. Global Protective Coatings Market (US$ Mn)

    4.2. Diabetic Retinopathy Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis 

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact 

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Protective Coatings Market Growth

        4.5.3. Diabetic Retinopathy Adoption Rate, By Country

    4.6. Market Dynamics 

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Diabetic Retinopathy Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Diabetic Retinopathy Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Diabetic Retinopathy Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032

        8.3.1. Proliferative

        8.3.2. Non-proliferative

    8.4. Market Attractiveness Analysis By Type

9. Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Management

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Management, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Management, 2022-2032

        9.3.1. Anti VEGF

        9.3.2. Intraocular steroid injection

        9.3.3. Laser surgery

        9.3.4. Vitrectomy

    9.4. Market Attractiveness Analysis By Management

10. Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific 

        10.3.5. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. U.S.

            11.4.1.2. Canada

            11.4.1.3. Rest of North America

        11.4.2. By Type

        11.4.3. By Management

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Type

        11.5.3. By Management

12. Latin America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Brazil

            12.4.1.2. Mexico

            12.4.1.3. Rest of Latin America

        12.4.2. By Type

        12.4.3. By Management

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Type

        12.5.3. By Management

13. Europe Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Germany

            13.4.1.2. France

            13.4.1.3. U.K.

            13.4.1.4. Italy

            13.4.1.5. Benelux

            13.4.1.6. Nordic Countries

            13.4.1.7. Rest of Europe

        13.4.2. By Type

        13.4.3. By Management

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Type

        13.5.3. By Management

14. Asia Pacific Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. China

            14.4.1.2. Japan

            14.4.1.3. South Korea

            14.4.1.4. Rest of Asia Pacific

        14.4.2. By Type

        14.4.3. By Management

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Type

        14.5.3. By Management

15. Middle East and Africa Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. GCC Countries

            15.4.1.2. South Africa

            15.4.1.3. Turkey

            15.4.1.4. Rest of Middle East and Africa

        15.4.2. By Type

        15.4.3. By Management

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Type

        15.5.3. By Management

16. Key Countries Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. US Diabetic Retinopathy Market Analysis

        16.2.1. Value Proportion Analysis by Market Taxonomy

        16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.2.2.1. By Type

            16.2.2.2. By Management

    16.3. Canada Diabetic Retinopathy Market Analysis

        16.3.1. Value Proportion Analysis by Market Taxonomy

        16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.3.2.1. By Type

            16.3.2.2. By Management

    16.4. Mexico Diabetic Retinopathy Market Analysis

        16.4.1. Value Proportion Analysis by Market Taxonomy

        16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.4.2.1. By Type

            16.4.2.2. By Management

    16.5. Brazil Diabetic Retinopathy Market Analysis

        16.5.1. Value Proportion Analysis by Market Taxonomy

        16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.5.2.1. By Type

            16.5.2.2. By Management

    16.6. Germany Diabetic Retinopathy Market Analysis

        16.6.1. Value Proportion Analysis by Market Taxonomy

        16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.6.2.1. By Type

            16.6.2.2. By Management

    16.7. France Diabetic Retinopathy Market Analysis

        16.7.1. Value Proportion Analysis by Market Taxonomy

        16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.7.2.1. By Type

            16.7.2.2. By Management

    16.8. Italy Diabetic Retinopathy Market Analysis

        16.8.1. Value Proportion Analysis by Market Taxonomy

        16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.8.2.1. By Type

            16.8.2.2. By Management

    16.9. BENELUX Diabetic Retinopathy Market Analysis

        16.9.1. Value Proportion Analysis by Market Taxonomy

        16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.9.2.1. By Type

            16.9.2.2. By Management

    16.10. UK Diabetic Retinopathy Market Analysis

        16.10.1. Value Proportion Analysis by Market Taxonomy

        16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.10.2.1. By Type

            16.10.2.2. By Management

    16.11. Nordic Countries Diabetic Retinopathy Market Analysis

        16.11.1. Value Proportion Analysis by Market Taxonomy

        16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.11.2.1. By Type

            16.11.2.2. By Management

    16.12. China Diabetic Retinopathy Market Analysis

        16.12.1. Value Proportion Analysis by Market Taxonomy

        16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.12.2.1. By Type

            16.12.2.2. By Management

    16.13. Japan Diabetic Retinopathy Market Analysis

        16.13.1. Value Proportion Analysis by Market Taxonomy

        16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.13.2.1. By Type

            16.13.2.2. By Management

    16.14. South Korea Diabetic Retinopathy Market Analysis

        16.14.1. Value Proportion Analysis by Market Taxonomy

        16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.14.2.1. By Type

            16.14.2.2. By Management

    16.15. GCC Countries Diabetic Retinopathy Market Analysis

        16.15.1. Value Proportion Analysis by Market Taxonomy

        16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.15.2.1. By Type

            16.15.2.2. By Management

    16.16. South Africa Diabetic Retinopathy Market Analysis

        16.16.1. Value Proportion Analysis by Market Taxonomy

        16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.16.2.1. By Type

            16.16.2.2. By Management

    16.17. Turkey Diabetic Retinopathy Market Analysis

        16.17.1. Value Proportion Analysis by Market Taxonomy

        16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.17.2.1. By Type

            16.17.2.2. By Management

        16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

    17.1. Market Analysis by Tier of Companies 

    17.2. Market Concentration

    17.3. Market Share Analysis of Top Players

    17.4. Market Presence Analysis

        17.4.1. By Regional footprint of Players

        17.4.2. Product footprint by Players

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive 

        18.3.1. Bayer Healthcare

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Sales Footprint

            18.3.1.4. Strategy Overview

        18.3.2. Novartis AG

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Sales Footprint

            18.3.2.4. Strategy Overview

        18.3.3. Regeneron Pharmaceuticals Inc.

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Sales Footprint

            18.3.3.4. Strategy Overview

        18.3.4. Allergan plc

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Sales Footprint

            18.3.4.4. Strategy Overview

        18.3.5. Oxurion

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Sales Footprint

            18.3.5.4. Strategy Overview

        18.3.6. Sirnaomics, Inc.

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Sales Footprint

            18.3.6.4. Strategy Overview

        18.3.7. Genentech

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio

            18.3.7.3. Sales Footprint

            18.3.7.4. Strategy Overview

        18.3.8. Glycadia Pharmaceuticals

            18.3.8.1. Overview

            18.3.8.2. Product Portfolio

            18.3.8.3. Sales Footprint

            18.3.8.4. Strategy Overview

        18.3.9. Alimera Sciences

            18.3.9.1. Overview

            18.3.9.2. Product Portfolio

            18.3.9.3. Sales Footprint

            18.3.9.4. Strategy Overview

        18.3.10. Ampio Pharmaceuticals

            18.3.10.1. Overview

            18.3.10.2. Product Portfolio

            18.3.10.3. Sales Footprint

            18.3.10.4. Strategy Overview

        18.3.11. BCN Peptides

            18.3.11.1. Overview

            18.3.11.2. Product Portfolio

            18.3.11.3. Sales Footprint

            18.3.11.4. Strategy Overview

        18.3.12. Kowa Group

            18.3.12.1. Overview

            18.3.12.2. Product Portfolio

            18.3.12.3. Sales Footprint

            18.3.12.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 2: Global Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 3: Global Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 4: Global Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 5: Global Diabetic Retinopathy Market, By Region, 2015 – 2021

Table 6: Global Diabetic Retinopathy Market, By Region, 2022 – 2032

Table 7: North America Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 8: North America Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 9: North America Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 10: North America Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 11: North America Diabetic Retinopathy Market, By Country, 2015 – 2021

Table 12: North America Diabetic Retinopathy Market, By Country, 2022 – 2032

Table 13: Latin America Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 14: Latin America Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 15: Latin America Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 16: Latin America Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 17: Latin America Diabetic Retinopathy Market, By Country, 2015 – 2021

Table 18: Latin America Diabetic Retinopathy Market, By Country, 2022 – 2032

Table 19: Europe Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 20: Europe Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 21: Europe Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 22: Europe Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 23: Europe Diabetic Retinopathy Market, By Country, 2015 – 2021

Table 24: Europe Diabetic Retinopathy Market, By Country, 2022 – 2032

Table 25: Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 26: Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 27: Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 28: Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 29: Asia Pacific Diabetic Retinopathy Market, By Country, 2015 – 2021

Table 30: Asia Pacific Diabetic Retinopathy Market, By Country, 2022 – 2032

Table 31: MEA Diabetic Retinopathy Market Value (US$ Mn), By Type, 2015 – 2021

Table 32: MEA Diabetic Retinopathy Market Value (US$ Mn), By Type, 2022 – 2032

Table 33: MEA Diabetic Retinopathy Market Value (US$ Mn), By Management, 2015 – 2021

Table 34: MEA Diabetic Retinopathy Market Value (US$ Mn), By Management, 2022 – 2032

Table 35: MEA Diabetic Retinopathy Market, By Country, 2015 – 2021

Table 36: MEA Diabetic Retinopathy Market, By Country, 2022 – 2032

Table 37: Global Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 38: Global Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 39: Global Diabetic Retinopathy Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 40: North America Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 41: North America Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 42: North America Diabetic Retinopathy Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 43: Latin America Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 44: Latin America Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 45: Latin America Diabetic Retinopathy Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 46: Europe Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 47: Europe Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 48: Europe Diabetic Retinopathy Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 49: Asia Pacific Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 50: Asia Pacific Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 51: Asia Pacific Diabetic Retinopathy Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 52: MEA Diabetic Retinopathy Market Incremental $ Opportunity, By Type, 2015 - 2021

Table 53: MEA Diabetic Retinopathy Market Incremental $ Opportunity, By Management, 2022 – 2032

Table 54: MEA Diabetic Retinopathy Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Diabetic Retinopathy Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 4: Global Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 5: Global Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 6: Global Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 7: Global Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 8: Global Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 9: Global Diabetic Retinopathy Market Share, By Region, 2022 & 2032

Figure 10: Global Diabetic Retinopathy Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 11: Global Diabetic Retinopathy Market Attractiveness Index, By Region – 2022-2032

Figure 12: North America Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 13: North America Diabetic Retinopathy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 14: North America Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 15: North America Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 16: North America Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 17: North America Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 18: North America Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 19: North America Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 20: North America Diabetic Retinopathy Market Share, By Country, 2022 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 22: North America Market Attractiveness Index, By Country – 2022-2032

Figure 23: Latin America Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 24: Latin America Diabetic Retinopathy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 25: Latin America Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 26: Latin America Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 27: Latin America Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 28: Latin America Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 29: Latin America Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 30: Latin America Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 31: Latin America Diabetic Retinopathy Market Share, By Country, 2022 & 2032

Figure 32: Latin America Diabetic Retinopathy Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 33: Latin America Diabetic Retinopathy Market Attractiveness Index, By Country – 2022-2032

Figure 34: Europe Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 35: Europe Diabetic Retinopathy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 36: Europe Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 37: Europe Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 38: Europe Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 39: Europe Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 40: Europe Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 41: Europe Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 42: Europe Diabetic Retinopathy Market Share, By Country, 2022 & 2032

Figure 43: Europe Diabetic Retinopathy Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 44: Europe Diabetic Retinopathy Market Attractiveness Index, By Country – 2022-2032

Figure 45: MEA Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 46: MEA Diabetic Retinopathy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 47: MEA Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 48: MEA Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 49: MEA Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 50: MEA Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 51: MEA Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 52: MEA Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 53: MEA Diabetic Retinopathy Market Share, By Country, 2022 & 2032

Figure 54: MEA Diabetic Retinopathy Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 55: MEA Diabetic Retinopathy Market Attractiveness Index, By Country – 2022-2032

Figure 56: Asia Pacific Diabetic Retinopathy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 57: Asia Pacific Diabetic Retinopathy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 58: Asia Pacific Diabetic Retinopathy Market Share, By Type, 2022 & 2032

Figure 59: Asia Pacific Diabetic Retinopathy Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 60: Asia Pacific Diabetic Retinopathy Market Attractiveness Index, By Type – 2022-2032

Figure 61: Asia Pacific Diabetic Retinopathy Market Share, By Management, 2022 & 2032

Figure 62: Asia Pacific Diabetic Retinopathy Market Y-o-Y Growth Projections, By Management – 2022-2032

Figure 63: Asia Pacific Diabetic Retinopathy Market Attractiveness Index, By Management – 2022-2032

Figure 64: Asia Pacific Diabetic Retinopathy Market Share, By Country, 2022 & 2032

Figure 65: Asia Pacific Diabetic Retinopathy Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 66: Asia Pacific Diabetic Retinopathy Market Attractiveness Index, By Country – 2022-2032

Figure 67: US Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: US Diabetic Retinopathy Market Share, By Type, 2021

Figure 69: US Diabetic Retinopathy Market Share, By Management, 2021

Figure 70: Canada Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 71: Canada Diabetic Retinopathy Market Share, By Type, 2021

Figure 72: Canada Diabetic Retinopathy Market Share, By Management, 2021

Figure 73: Brazil Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: Brazil Diabetic Retinopathy Market Share, By Type, 2021

Figure 75: Brazil Diabetic Retinopathy Market Share, By Management, 2021

Figure 76: Mexico Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 77: Mexico Diabetic Retinopathy Market Share, By Type, 2021

Figure 78: Mexico Diabetic Retinopathy Market Share, By Management, 2021

Figure 79: Germany Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Germany Diabetic Retinopathy Market Share, By Type, 2021

Figure 81: Germany Diabetic Retinopathy Market Share, By Management, 2021

Figure 82: U.K. Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 83: U.K. Diabetic Retinopathy Market Share, By Type, 2021

Figure 84: U.K. Diabetic Retinopathy Market Share, By Management, 2021

Figure 85: France Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: France Diabetic Retinopathy Market Share, By Type, 2021

Figure 87: France Diabetic Retinopathy Market Share, By Management, 2021

Figure 88: Italy Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 89: Italy Diabetic Retinopathy Market Share, By Type, 2021

Figure 90: Italy Diabetic Retinopathy Market Share, By Management, 2021

Figure 91: BENELUX Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 92: BENELUX Diabetic Retinopathy Market Share, By Type, 2021

Figure 93: BENELUX Diabetic Retinopathy Market Share, By Management, 2021

Figure 94: Nordic Countries Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 95: Nordic Countries Diabetic Retinopathy Market Share, By Type, 2021

Figure 96: Nordic Countries Diabetic Retinopathy Market Share, By Management, 2021

Figure 97: China Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: China Diabetic Retinopathy Market Share, By Type, 2021

Figure 99: China Diabetic Retinopathy Market Share, By Management, 2021

Figure 100: Japan Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 101: Japan Diabetic Retinopathy Market Share, By Type, 2021

Figure 102: Japan Diabetic Retinopathy Market Share, By Management, 2021

Figure 103: South Korea Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 104: South Korea Diabetic Retinopathy Market Share, By Type, 2021

Figure 105: South Korea Diabetic Retinopathy Market Share, By Management, 2021

Figure 106: GCC Countries Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 107: GCC Countries Diabetic Retinopathy Market Share, By Type, 2021

Figure 108: GCC Countries Diabetic Retinopathy Market Share, By Management, 2021

Figure 109: South Africa Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: South Africa Diabetic Retinopathy Market Share, By Type, 2021

Figure 111: South Africa Diabetic Retinopathy Market Share, By Management, 2021

Figure 112: Turkey Diabetic Retinopathy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 113: Turkey Diabetic Retinopathy Market Share, By Type, 2021

Figure 114: Turkey Diabetic Retinopathy Market Share, By Management, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Diabetic Retinopathy Market

Published : June 2022

Healthcare

Diabetic Nephropathy Market

Published : December 2016

Healthcare

Diabetic Shoes Market

Published : February 2022

Healthcare

Diabetes Care Devices Market

Published : January 1970

Google translate

Diabetic Retinopathy Market